Tianjin Lisheng Pharmaceutical Co.,Ltd. (SHE:002393)

China flag China · Delayed Price · Currency is CNY
21.79
+0.10 (0.46%)
Feb 27, 2026, 3:04 PM CST
Market Cap5.58B +28.7%
Revenue (ttm)1.32B +4.3%
Net Income386.02M +104.9%
EPS1.50 +105.3%
Shares Out256.15M
PE Ratio14.51
Forward PEn/a
Dividend0.35 (1.61%)
Ex-Dividend DateFeb 11, 2026
Volume1,822,215
Average Volume3,109,452
Open21.59
Previous Close21.69
Day's Range21.59 - 22.05
52-Week Range14.90 - 28.77
Beta0.24
RSI48.55
Earnings DateMar 25, 2026

About SHE:002393

Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers its products in various forms comprising tablets, capsules, granules, and injections for use in various therapeutic fields, such as nervous system, musculoskeletal, genitourinary system, antineoplastic and immune system, sensory system, systemic anti-infection, respiratory system, endocrine system, digestive system, and cardiovascular system, as well as drugs for invigo... [Read more]

Sector Healthcare
Founded 1951
Employees 1,604
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002393
Full Company Profile

Financial Performance

In 2024, SHE:002393's revenue was 1.34 billion, an increase of 15.88% compared to the previous year's 1.15 billion. Earnings were 184.53 million, a decrease of -49.00%.

Financial Statements